Patients with elderly-onset diabetes have specific characteristics. This study was designed to investigate these characteristics and to evaluate methods for appropriate control of glycaemia and cardiovascular risk factors in elderly-onset diabetes patients. A total of 155 elderly patients with type 2 diabetes mellitus were divided into those diagnosed at ≥ 65 years of age (elderly-onset group, 75 patients) and those diagnosed at < 60 years of age (usual-onset group, 80 patients). Differences in clinical variables, diabetic complications, diagnosed comorbidities and the use of medications were analysed. Mean glycosylated haemoglobin, fasting plasma glucose and fasting insulin levels were significantly lower in the elderlyonset group than in the usual-onset group. The usual-onset group showed significantly greater homeostasis model assessment insulin resistance than the elderly-onset group. Microvascular complications and insulin use were significantly more common in the usualonset group. In conclusion, insulin resistance was less severe in elderly-onset diabetes than in usual-onset diabetes. As hyperglycaemia was relatively mild or moderate, oral hypoglycaemic agents might be effective for elderly-onset diabetes.
Introduction
Type 2 diabetes mellitus is now at epidemic levels in China and is expected to become even more prevalent over the next few decades. 1 One survey estimated that there are 40 million people with diabetes in China. 2 Another reported that the prevalence of type 2 diabetes mellitus was 11.34% in people aged > 65 years old. 3 Although there are many studies of elderly patients with type 2 diabetes mellitus, 4 very few have focused on elderly-onset diabetes mellitus in China.
In clinical practice, we have found that patients with elderly-onset diabetes show specific characteristics that differ from those of middle-aged-onset diabetes or early-onset diabetes. The present study was designed to Y Wang, M-Z Qin, Q Liu et al. Clinical analysis of elderly-onset type 2 diabetes in China compare the clinical characteristics of elderly-onset type 2 diabetes mellitus with those of middle-aged (usual)-onset diabetes in Chinese patients. The prevalence of diabetic complications and comorbidities was also assessed, and the effect of treatment on clinical outcomes in these patients was examined.
Patients and methods

PATIENTS AND SAMPLES
Elderly Chinese patients (≥ 65 years of age) with type 2 diabetes mellitus who were either hospitalized or were outpatients at the Department of Geriatrics, Beijing Tong Ren Hospital, Capital Medical University, Beijing, China, were enrolled in the study between January 2008 and July 2009. Those who were diagnosed with diabetes when they were ≥ 65 years of age were referred to as the elderlyonset group and those diagnosed with diabetes at age < 60 years were referred to as the usual-onset group. Patients who were diagnosed between 60 and 65 years of age were considered pre-elderly and were excluded from the study. For all patients, type 2 diabetes mellitus was defined according to the World Health Organization criteria. 5 Patients with a diagnosis of type 1 diabetes mellitus were excluded from the study. The assessment of patients' diabetes status was based on inpatient and outpatient case records.
This study was approved by the Ethics Review Board of Beijing Tongren Hospital affiliated to Capital Medical University (Beijing, China). Written informed consent was obtained from all patients for data analysis and reporting.
CLINICAL AND LABORATORY MEASUREMENTS
For each patient, general characteristics were recorded including: body height; weight; body mass index (BMI, weight [kg]/height [m] 2 ); waist circumference (WC); and blood pressure.
The following clinical laboratory variables were recorded using standard laboratory techniques: glycosylated haemoglobin (HbA 1c ); fasting plasma glucose (FPG); 2-h post-prandial plasma glucose (PPG); fasting insulin (FINS); and glucose/insulin homeostasis indicators calculated as homeostasis model assessment (HOMA) insulin resistance (HOMA-IR = [FINS (µU/ml) × FPG (mmol/l)]/22.5), and as HOMA β-cell index (HOMA-β = [20 × FINS (µU/ml)]/[FPG (mmol/l) -3.5]). 6 Lipid measurements included total cholesterol (TC), triglyceride (TG), lowdensity lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol. Renal function variables included urine albumin elimination rate (UAER), plasma creatinine (Cr) and calculated creatinine clearance (CrCl), which was estimated using the Cockcroft-Gault formula (CrCl = [(140 -A) × W × K]/Cr), where K = 1.23 for men and 1.04 for women, A is age in years, W is body weight in kg and Cr is plasma creatinine in µmol/l). 7 Each patient underwent a comprehensive assessment of complications and comorbidities. Patients were defined as having microvascular complications if they had evidence of retinopathy, abnormal foot sensations or an abnormal UAER (> 20 µg/min). Patients were defined as having macrovascular complications if they had evidence of ischaemic heart disease, cerebrovascular disease or peripheral vascular arteriosclerosis. Peripheral vascular examinations were performed on a GE Vivid Five ultrasound machine (GE Medical Systems, Slough, UK). Comorbidities were recorded based on the International Classification of Disease 10th revision (ICD- 
STATISTICAL ANALYSIS
All analyses were performed using the SPSS ® statistical package, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Continuous values are expressed as mean ± SD and categorical variables are presented as frequency (n, %). The UAER was logarithmically transformed for statistical tests because of a skewed distribution. A Student's t-test was used to compare continuous variables and Pearson's χ 2 -test was used to compare categorical variables. Differences were considered statistically significant at the α level of 0.05.
Results
In total, 155 elderly patients with type 2 diabetes mellitus (92 males, 63 females; mean age ± SD, 72.0 ± 8.7 years) were analysed. Of these, 75 patients had been diagnosed with diabetes at ≥ 65 years of age and formed the elderly-onset group (43 males, 32 females; mean age ± SD, 75.4 ± 6.0 years). The other 80 patients had been diagnosed with diabetes at < 60 years of age and formed the usual-onset group (49 males, 31 females; mean age ± SD, 69.4 ± 3.8 years). The demographic and general characteristics of the two groups of patients are summarized in Table 1 . There were no significant differences between the elderlyonset and usual-onset groups in any demographics or general clinical characteristics other than for age and mean age of diagnosis (P = 0.001). Table  2 compares the clinical characteristics between the two groups. Significantly higher mean ± SD levels of HbA 1c (P = 0.033), FPG (P = 0.019), FINS (P = 0.012), HOMA-IR (P = 0.007), UAER (P = 0.022), TG (P = 0.049) and LDL cholesterol (P = 0.042), and a significantly higher percentage of patients with UAER ≥ 20 Table 3 . Only the percentage of patients with microvascular complications was statistically significantly higher in the usual-onset group compared with the elderly-onset group (P = 0.033).
Analysis of the medications used by patients in both groups is shown in Table 4 . Use of acarbose was significantly higher (P = 0.049) and the use of insulin (either alone or in combination with oral agents) was significantly lower (P = 0.038) in the elderlyonset group compared with the usual-onset group. There were no cases of symptomatic hypoglycaemia reported by the study subjects over 1 year. Few episodes of asymptomatic subclinical hypoglycaemia (glucose levels 3.4 -4.5 mmol/l) were detected by memory glucose meter monitoring in the elderly-onset and usual-onset groups (2.7% versus 6.3%, respectively).
Discussion
This study describes and compares two groups of patients with type 2 diabetes mellitus attending a single diabetes clinic. Although mean FPG and PPG were both lower in the elderly-onset group than in the usual-onset group, only FPG was statistically significantly lower. This difference was considered to be due to the pathogenesis of elderly-onset diabetes; 'hyperglycaemia of ageing' is a characteristic finding of elderlyonset diabetes. 8 The significantly lower HbA 1c level in the elderly-onset diabetes patients also supported our clinical impression about these patients.
Type 2 diabetes is characterized by insulin resistance and pancreatic β-cell dysfunction, as has been shown by the measures of HOMA-IR and HOMA-β. 9 In the present study, HOMA-IR was significantly higher in 
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the usual-onset group than in the elderlyonset group, whereas HOMA-β was not significantly different between the two groups. This suggests that individuals who develop diabetes in middle-age show more severe insulin resistance than patients who develop diabetes later in life. Insulin resistance may be present before the disease manifests itself; for example, insulin resistance has been observed in first-degree relatives of patients with diabetes. 10 In the present study, the TG and LDL cholesterol levels were significantly higher in the usualonset group compared with the elderly-onset group. Although BMI and WC were both higher in the usual-onset group than in the elderly-onset group, the differences were not statistically significant. Nevertheless, a tendency towards unhealthy high-fat diets, sedentary lifestyles, obesity and metabolic defects is likely to contribute to an increased prevalence of middle-age-onset diabetes. Decreased insulin sensitivity in the elderly is not, however, a benign process. Indeed, there is a suggestion from the present results that the reduced insulin secretion associated with elderly-onset diabetes patients who show mild or moderate hyperglycaemia and a low incidence of microvascular complications might occur as a result of an age-related decrease in β-cell function.
The percentage HbA 1c reflects the extent of glycaemic control over the preceding 3 months and is an important guide for the clinical management of diabetes. 11 The recently halted Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial showed that intensive therapy of type 2 diabetes mellitus was associated with increased mortality. 12 -14 Its premature discontinuation was due to increased mortality in the group of patients allocated to intensive therapy to reduce HbA 1c below 6%. 12 -14 In the present study study, the mean HbA 1c for both groups was lower than that reported in some previous studies, 15 -17 but higher than that reported in a German study. 18 More than half of the patients in the present study failed to attain optimal levels of glycaemic control, according to European guidelines 19 in which HbA 1c ≤ 6.5% is considered to be the optimal target for glycaemic control. Although the mean HbA 1c was not ideal in the present study, the rate of hypoglycaemia was lower than that reported in other trials. 20, 21 This suggests that it might be safe and effective for the HbA 1c target for elderly diabetic patients to be broadened to HbA 1c values of 6.5 -7.0%.
Since the FPG level was lower in the elderly-onset patients in the present study than in the usual-onset patients, the main problem in the elderly-onset patients was the elevation in PPG. Traditional Chinese diets are characterized and dominated by highglycaemic carbohydrates; 22 thus, αglucosidase inhibitors are considered to be useful and relatively safe therapeutic options for elderly diabetes patients. 23, 24 The overall control of cardiovascular risk factors is important to delay progression of type 2 diabetes in elderly patients. 25 In addition to hypoglycaemic agents, concomitant medications providing antihypertensive, antihyperlipidaemic and antiplatelet effects, and the use of nonsublingual nitrates, were extensively used in the present patient cohort, particularly the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, calcium channel blockers, aspirin and statins. Nevertheless, the levels of CrCl were not markedly impaired in either group. Similarly, the incidence of diabetes-related complications and comorbidities was not high compared with those reported in a previous study. 26 This was considered to be due to adequate control of blood pressure, lipids and • Received for publication 1 February 2010 • Accepted subject to revision 19 February 2010
• Revised accepted 21 April 2010 Copyright © 2010 Field House Publishing LLP renal function, as reported previously. 27 In conclusion, the pathogenesis of elderlyonset diabetes appears to be mainly due to a decreased β-cell function associated with ageing. Insulin resistance was less severe in elderly-onset diabetes than in usual-onset diabetes, hyperglycaemia was relatively mild or moderate and the incidence of diabetesrelated complications, particularly microvascular disease, was relatively lower in elderly-onset patients. As the basal FPG was not very high, hypoglycaemic therapy should focus on PPG; hence oral hypoglycaemic agents might be effective for elderly-onset diabetes. In addition, a target HbA 1c of 6.5 -7.0% might be more appropriate in elderly diabetic patients so as to delay disease progression and avoid severe hypoglycaemia. In clinical practice, concomitant therapy focusing on cardiovascular risk factor control could have a beneficial effect in elderly diabetic patients.
